Note: This is a new agreement commencing in January 2023.
Elsevier is a leader in information and analytics helping researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. As one of the world’s fastest growing access publishers, Elsevier enables open access in nearly all its 2,700+ journals, with 600+ dedicated open access journals.
The 2023 cap on this agreement is 7,138 articles.
This page was last updated on 16 June 2023.
Authors who do not see their institution listed above should contact library staff to enquire further.
*These institutions have access to a reduced title list, based on their subscribed subject collections.
This agreement allows authors from participating institutions to publish open access in 1649 titles with no transactional APCs. This includes high impact titles such as:
And titles with high Australian and New Zealand authorship, such as:
Titles not include in the agreement for open access publishing may still benefit from a 15% discount on open access article processing charges (APCs). Please check the full title list to see which journals offer a discount.
Open access publishing covered under this Read & Publish agreement includes the following article types:
Authors may publish excluded article types as “closed access” or pay an article processing charge (if applicable) to make the article open access.
Eligible articles that have an acceptance date during the term of this agreement (2023 - 2025) are eligible to be published open access under the terms of the agreement.
During the first half of 2023 CAUL and Elsevier operated a restricted title list of 235 journals. For articles accepted from 15 June 2023 onwards, this restriction was lifted and all 1649 eligible hybrid journals are now able to participate in this open access agreement.
This agreement provides for 7,138 articles to be published open access in 2023.
Corresponding authors from institutions listed under 'Participating institutions' may publish immediately to open access on the publisher's platform once the article has been accepted, with no transactional APCs.
Articles from authors at participating institutions may be published under the authors' choice of either
The Creative Commons licenses allow reuse (some with conditions) while protecting the authors' rights of acknowledgment as authors. Authors retain copyright.
Please note: Under the CC BY-NC-ND license and for the Elsevier user license permitted 3rd party reuse is only applicable for non-commercial purposes. For further details on the rights granted to Elsevier see our copyright information or to obtain permission for commercial use see our permission information. Also note further permission may be required from the rights owner for any content within an article that is identified as belonging to a third party.
Authors will be identified as eligible for open access publishing by their institutional affiliation.
Authors must use their institutional email address when submitting an article for publication in order for the publication to be approved to be published open access with no transactional APCs.
The license is available for download from ConsortiaManager. Library staff should contact the designated Content Coordinator at their institution regarding any license enquiries.
The agreement provides access to all journals listed under ‘Included titles’.
Authors may deposit articles in institutional repositories.
View the publisher’s policy on article sharing for further information.
The publisher will supply CAUL Procurement Services with reports on publishing output with article-level information monthly. CAUL will share publishing output data with participating institutions on a regular basis.